HEPACORE LTD has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are VIREXX MEDICAL CORP, NAT INSTITUTE OF IMMUNOLOGY and YI JINYANG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Canada | 2 | |
#5 | Israel | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Macromolecular chemistry and polymers | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Object sterilising | |
#5 | Microorganisms | |
#6 | Macromolecular compounds compositions | |
#7 | Specific use of cosmetics | |
#8 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Yayon Avner | 16 |
#2 | Amit Boaz | 6 |
#3 | Sirkis Roy | 5 |
#4 | Rom Eran | 5 |
#5 | Rozen Nimrod | 4 |
#6 | Lewinson Dina | 4 |
#7 | Chumakov Irina | 3 |
#8 | Wortzel Avraham | 3 |
#9 | Barkay-Olami Hilla | 3 |
#10 | Blumenstein Sara | 3 |
Publication | Filing date | Title |
---|---|---|
US2013084278A1 | Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof | |
WO2012140650A2 | Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof | |
WO2012038953A2 | Fgf-18 truncated variants having increased receptor specificity and uses thereof | |
IL194694D0 | Endothelial progenitor cell preparations for bone regeneration | |
WO2008081463A2 | Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof | |
WO2008038287A2 | N-terminal fgf variants having increased receptor selectivity and uses thereof | |
CA2649729A1 | Methods for bone regeneration using endothelial progenitor cell preparations |